Shorla Oncology and Eversana announce US launch of first ora

Irish pharmaceutical company Shorla Oncology and consultancy firm Eversana have announced the U.S. launch of JYLAMVO, the first oral methotrexate solution.

Related Keywords

Jim Lang , Sharon Cunningham , , Shorla Oncology , Bio Developments , Markets Amp Regulations , Pipelines , Emerging Markets , Leukemia , Acute Lymphoblastic Leukemia , Dancer , Ncology ,